12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CPP-115: Phase Ia start

Catalyst disclosed in its 3Q11 earnings that this quarter it will begin a U.S. Phase Ia trial to...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >